The Lab Tests Behind Immuno-Oncology: Precise Enough? – Forbes
Forbes |
The Lab Tests Behind Immuno-Oncology: Precise Enough?
Forbes In contrast, a second high-profile I/O approach, the use of engineered CAR-T (Chimeric Antigen Receptor T-cell) cells, works by directly engineering a mechanism into T-cells that allows them to target certain cancer cells while at the same time “hot … |
